Use of inhalant medications with and without chlorofluorocarbon propellants in the United States, 1996-2000.
Wysowski
Diane K
DK
Division of Drug Risk Evaluation, Office of Drug Safety, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD 20857, USA.
Swann
Joslyn
J
D000280:Administration, Inhalation; D000335:Aerosol Propellants; D017402:Chlorofluorocarbons; D017277:Drug Approval; D017723:Drug Utilization Review; D006801:Humans; D009330:Nebulizers and Vaporizers / Q000145:classification* / Q000706:statistics & numerical data; D012140:Respiratory Tract Diseases / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
D000335:Aerosol Propellants; D017402:Chlorofluorocarbons